We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Chart Industries (GTLS) Enters Into Partnership With Cryomotive
Read MoreHide Full Article
Chart Industries, Inc. (GTLS - Free Report) recently announced that it has entered into a collaboration with Cryomotive GmbH to develop the latter’s cryogenic storage and refueling technology.
Notably, Chart Industries’ shares moved down 2.8% to eventually close the trading session at $147.24, yesterday.
Cryomotive, a renowned green-tech mobility company in Germany, is engaged in developing a disruptive clean hydrogen storage and refueling technology platform for decarbonizing various sectors including industry, energy and mobility. The company’s patented CcH2 CRYOGAS technology is designed to decarbonize commercial vehicles with range and fueling times targeted to be kept similar to that of their diesel powered counterparts.
Inside the Headlines
The partnership includes Chart Industries’ minority investment in Cryomotive for €6.5 million and a commercial agreement. Notably, the partnership will allow Cryomotive to utilize its patented technology together with Chart Industries, supported by the latter’s in-depth knowledge in refueling and hydrogen station market. With Cryomotive’s solid hydrogen commercial relationships with vehicle manufacturers in Germany, China and Japan, Chart Industries is likely to benefit from increased commercial opportunities for its hydrogen equipment.
It’s worth noting here that the partnership will help Chart Industries to expand its hydrogen addressable market by $100 million in the next five years.
Other Growth Enhancing Actions
The partnership is in sync with Chart Industries’ focus on investing in businesses to gain access to new customers, regions and product lines.
In late March 2021, Chart Industries acquired a 5% stake in Transform Materials, a chemical technology company, for $25 million. The investment will enable it to expand its presence and prospects in the clean-energy markets, particularly hydrogen.
Also, in December 2020, it completed the acquisition of Sustainable Energy Solutions, Inc. In addition, in November, the company acquired Worthington Industries, Inc.’s (WOR - Free Report) cryogenic trailer and hydrogen trailer business in Theodore, AL.
Zacks Rank, Price Performance and Earnings Trend
Chart Industries, with a market capitalization of $5.4 billion, carries a Zacks Rank #3 (Hold). The company is poised to gain from solid product offerings, higher orders, planned investments and cost-saving measures. However, high debt level remains concerning.
In the past three months, its shares have gained 5.6% compared with the industry’s growth of 11.8%.
The Zacks Consensus Estimate for its 2021 earnings has improved 4.6% to $3.90 in the past 30 days on the back of three upward revisions against none downward. Also, estimates for 2022 increased 1% to $5.19 on five upward revisions versus one downward.
Applied Industrial delivered an earnings surprise of 30.33%, on average, in the trailing four quarters.
Parker-Hannifin delivered an earnings surprise of 37.36%, on average, in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Chart Industries (GTLS) Enters Into Partnership With Cryomotive
Chart Industries, Inc. (GTLS - Free Report) recently announced that it has entered into a collaboration with Cryomotive GmbH to develop the latter’s cryogenic storage and refueling technology.
Notably, Chart Industries’ shares moved down 2.8% to eventually close the trading session at $147.24, yesterday.
Cryomotive, a renowned green-tech mobility company in Germany, is engaged in developing a disruptive clean hydrogen storage and refueling technology platform for decarbonizing various sectors including industry, energy and mobility. The company’s patented CcH2 CRYOGAS technology is designed to decarbonize commercial vehicles with range and fueling times targeted to be kept similar to that of their diesel powered counterparts.
Inside the Headlines
The partnership includes Chart Industries’ minority investment in Cryomotive for €6.5 million and a commercial agreement. Notably, the partnership will allow Cryomotive to utilize its patented technology together with Chart Industries, supported by the latter’s in-depth knowledge in refueling and hydrogen station market. With Cryomotive’s solid hydrogen commercial relationships with vehicle manufacturers in Germany, China and Japan, Chart Industries is likely to benefit from increased commercial opportunities for its hydrogen equipment.
It’s worth noting here that the partnership will help Chart Industries to expand its hydrogen addressable market by $100 million in the next five years.
Other Growth Enhancing Actions
The partnership is in sync with Chart Industries’ focus on investing in businesses to gain access to new customers, regions and product lines.
In late March 2021, Chart Industries acquired a 5% stake in Transform Materials, a chemical technology company, for $25 million. The investment will enable it to expand its presence and prospects in the clean-energy markets, particularly hydrogen.
Also, in December 2020, it completed the acquisition of Sustainable Energy Solutions, Inc. In addition, in November, the company acquired Worthington Industries, Inc.’s (WOR - Free Report) cryogenic trailer and hydrogen trailer business in Theodore, AL.
Zacks Rank, Price Performance and Earnings Trend
Chart Industries, with a market capitalization of $5.4 billion, carries a Zacks Rank #3 (Hold). The company is poised to gain from solid product offerings, higher orders, planned investments and cost-saving measures. However, high debt level remains concerning.
In the past three months, its shares have gained 5.6% compared with the industry’s growth of 11.8%.
The Zacks Consensus Estimate for its 2021 earnings has improved 4.6% to $3.90 in the past 30 days on the back of three upward revisions against none downward. Also, estimates for 2022 increased 1% to $5.19 on five upward revisions versus one downward.
Stocks to Consider
A couple of better-ranked stocks from the same space are Applied Industrial Technologies, Inc. (AIT - Free Report) and Parker-Hannifin Corporation (PH - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Applied Industrial delivered an earnings surprise of 30.33%, on average, in the trailing four quarters.
Parker-Hannifin delivered an earnings surprise of 37.36%, on average, in the trailing four quarters.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>